Visceral fat resection in humans: Effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers

Obesity

Volumn 21, Issue 3, 2013, Pages

  Lima, Marcelo M O ^a   Pareja, Jose C ^a   Alegre, Sarah M ^a   Geloneze, Sylka R ^a   Kahn, Steven E ^b   Astiarraga, Brenno D ^a   Chaim, Élinton A ^a   Baracat, Jamal ^a   Geloneze, Bruno ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FAT; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; ARTICLE; BODY COMPOSITION; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; ECHOGRAPHY; FAT MASS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEUKOCYTE COUNT; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; OBESITY; OMENTECTOMY; PANCREAS ISLET BETA CELL; RANDOMIZED CONTROLLED TRIAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL FAT RESECTION; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; LEPTIN; METABOLIC SYNDROME X; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PREMENOPAUSE; PROSPECTIVE STUDIES; RESISTIN; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; YOUNG ADULT;

EID: 84876490482     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20030     Document Type: Article

References (25)

1. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094.
2. Boorsma W, Snijder MB, Nijpels G, et al. Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity (Silver Spring) 2008; 16: 2696-2701.
3. Hansen E, Hajri T, Abumrad NN,. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. Surgery 2006; 139: 711-716.
4. Frayn KN,. Visceral fat and insulin resistance-causative or correlative? Br J Nutr 2000; 83 (Suppl 1): S71-S77.
5. Lebovitz HE, Banerji MA,. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 2005; 28: 2322-2325.
6. Miles JM, Jensen MD,. Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 2005; 28: 2326-2328
7. Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48: 94-98.
8. Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002; 51: 2951-2958.
9. Pitombo C, Araújo EP, Souza CT, Pareja JC, Geloneze B, Velloso LA,. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol 2006; 191: 699-706.
10. Lottati M, Kolka CM, Stefanovski D, Kirkman EL, Bergman RN,. Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring) 2009; 17: 674-680.
11. Thorne A, Lonnqvist F, Apelman J, et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002; 26: 193-199.
12. Csendes A, Maluenda F, Burgos AM,. A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg 2009; 19: 490-494.
13. Herrera MF, Pantoja JP, Velázquez-Fernández D, et al. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial. Diabetes Care 2010; 33: 1413-1418.
14. Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010; 139: 448-455.
15. Alberti KG, Zimmet P, Shaw J,. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
16. Lima MM, Pareja JC, Alegre SM, et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic- hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3871-3875.
17. Muscelli E, Mingrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005; 118: 51-57.
18. Chen M, Porte D Jr,. The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab 1976; 42: 1168-1175.
19. Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF,. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 2011; 300: E255-E262.
20. Cunningham JM, Green IC,. Cytokines, nitric oxide and insulin secreting cells. Growth Regul 1994; 4: 173-180.
21. Dula SB, Jecmenica M, Wu R, et al. Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium 2010; 48: 133-142.
22. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14: 15-23.
23. Groop LC, Widén E, Ferrannini E,. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 1993; 36: 1326-1331.
24. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM,. C-reactive protein, interleukin 6 and risk of developing type 2 diabetes. JAMA 2001; 286: 327-334.
25. Collins D, Hogan AM, O'Shea D, Winter DC,. The omentum: anatomical, metabolic, and surgical aspects. J Gastrointest Surg 2009; 13: 1138-1146.